Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis
Hana Forejtníková(Inserm), Frédèrique Verdier(Université Paris Cité), Maud Vieillevoye(Inserm), Rosa Maria Pellegrino, Clara Camaschella(San Raffaele University of Rome), Patrick Mayeux(Université Paris Cité), Muriel Gaudry(Inserm), Catherine Lacombe(Centre National de la Recherche Scientifique), Yaël Zermati(Délégation Paris 5), Soizic Guihard(Centre National de la Recherche Scientifique), Antonella Roetto(Vita-Salute San Raffaele University), Mireille Lambert(Inserm)
Cited by 149
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Iron metabolism and iron disorders revisited in the hepcidin era
|Haematologica|2020|676
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
|Haematologica|2009|316